Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal
Can transcranial direct current stimulation (tDCS) help to reduce the frequency of
seizures in adults and children with refractory focal epilepsy (epilepsy that cannot
be well controlled by seizure medication)?
Basic Study Information
Purpose:Location: University of Rochester
This is a multiple site, randomized, double blinded parallel-group controlled study.
The purpose of this study is to evaluate efficacy, safety, and tolerability of repeated,
daily sessions with the STARSTIM device, which delivers transcranial cathodal direct
current stimulation (tDCS). Subjects will be assigned to receive treatment with either
STARTSTIM or a sham device for 10 sessions over a 2-week period. The subjects will
be followed for an additional 10 weeks post treatment. Quality of Life questionnaires
and adverse events will be collected and evaluated.
Study Reference #: 00006545
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Cate Concannon
Phone: (585) 275-0589
Additional Study Details
For Vists #2 through #11 you will need to come to URMC every day, Monday through Friday,
for two weeks in a row for about 1.5 hours.
Number of Visits:
More than 10
Trial Not Found
The study you are looking for is not active at this time.
Return to Search